Dr. Fabrizio Bonanni retired in 2013 from his position as executive vice president at Amgen Inc. In his 14 years with the company, he served as senior vice president, Quality and Compliance and corporate compliance officer, senior vice president, Manufacturing, and finally as EVP Operations, overseeing the company's global production and supply chain activities as well as Quality, Process Development, Drug Delivery Devices, and Engineering.
While at Amgen, Bonanni served as a Trustee of the California Science Center, of the Los Angeles Museum of Contemporary Art, and of the Science Technology and Research Trust of Puerto Rico. He also served on the executive committee of the Board of BIO, the Biotechnology Industry Association.
Previously, he was corporate vice president, Regulatory and Clinical Affairs and corporate vice president, Quality System for Baxter International Inc., a company he joined in 1974. At Baxter, Bonanni spent half of his career in international operations, including an eight-year assignment as vice president, Quality and Regulatory Affairs at the company's European headquarters in Brussels, Belgium.
Bonanni earned his doctorate in chemistry, magna cum laude, mention of honor, from the University of Florence and did postdoctoral work in physiological chemistry at the Massachusetts Institute of Technology. He is an alumnus of the Institute for International Management, Northwestern University, J.L. Kellogg Graduate School of Management, and of the Executive Program in Manufacturing, Harvard University, Graduate School of Business Administration.
Currently, Dr. Bonanni is a member of the Board of the Stevanato Group, an Italian company developing and manufacturing high quality primary containers for the bio-pharma industry as well as manufacturing engineering solutions for glass container manufacturers.